Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New osteoporosis therapy prevents bone loss by directing mesenchymal stem cells to bone

Sep. 21, 2011

GWAS identifies new loci linked to susceptibility to Alzheimer's disease

Sep. 21, 2011

Takeda presents clinical and preclinical data on TAK-875 in diabetes

Sep. 21, 2011

Taisho sodium/glucose cotransporter 2 inhibitor shows promise in patients with type 2 diabetes

Sep. 20, 2011

Fluorocoxib probe may allow earlier diagnosis of nonmelanoma skin cancer

Sep. 20, 2011

Inhibitor of P. aeruginosa type III secretion system shows promise in preclinical studies

Sep. 20, 2011

Study identifies SNPs implicated in response to lithium therapy for bipolar disorder

Sep. 20, 2011

Preclinical and clinical data on migalastat made available

Sep. 20, 2011

SMART-5 trial data reported for bazedoxifene/conjugated estrogens

Sep. 19, 2011

Phase II trial evaluates FV-100 for pain associated with shingles

Sep. 19, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...